'They got a number of advanced-stage drugs that will probably be approved': Sissons on AstraZeneca – BNN Bloomberg

Skip to main content

ADVERTISEMENT

The Street

'They got a number of advanced-stage drugs that will probably be approved': Sissons on AstraZeneca

Darren Sissons, partner and portfolio manager at Campbell, Lee & Ross Investment Management, joins BNN Bloomberg to discuss stocks to keep on your radar.

March 20, 2026 at 9:38AM EDT

'Right now the bigger risk is underinvesting': NewmanOpens in new window

06:10 · May 13, 2026 at 9:33AM EDT

U.S. CPI increases to 3.8% in AprilOpens in new window

08:25 · May 12, 2026 at 9:43AM EDT

'Make no mistake, we are still bullish on gold as sort of an anti-fiat currency of sorts': MaddenOpens in new window

05:35 · May 12, 2026 at 9:36AM EDT

'We're working to give people access to money and to be able to buy a home': CMI Financial Group CEOOpens in new window

07:11 · May 11, 2026 at 9:30AM EDT

'They run a very efficient and tight ship, they've done very well': Graham on Power CorporationOpens in new window

04:57 · May 11, 2026 at 9:28AM EDT

Canada lost 17.7k jobs in AprilOpens in new window

08:44 · May 08, 2026 at 9:32AM EDT

Space becomes the next investment frontier: HullOpens in new window

06:12 · May 08, 2026 at 9:28AM EDT

Linamar reports low tariff impact in Q1Opens in new window

07:33 · May 07, 2026 at 9:29AM EDT

'There is no AI without these two countries': Mordy on South Korea and TaiwanOpens in new window

05:58 · May 07, 2026 at 9:24AM EDT

Are higher costs weighing on Suncor's earnings?Opens in new window

05:56 · May 06, 2026 at 9:46AM EDT